Rayomand Press
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Plasma cardiac troponin T complements neurofilament light chain by reflecting disease phase and phenotypic variation in amyotrophic lateral sclerosis.
Journal: Journal of neurology
Published: April 22, 2026
Protein Biomarkers in Risk and Prognosis of Amyotrophic Lateral Sclerosis.
Journal: European journal of neurology
Published: December 12, 2025
Novel Clinical Insights From a Swedish RFC1 Spectrum Disorder Cohort.
Journal: European journal of neurology
Published: August 17, 2025
Rituximab in New-Onset Generalized Myasthenia Gravis: Long-Term Follow-Up of the RINOMAX Clinical Trial.
Journal: European journal of neurology
Published: July 08, 2025
Use of Common Psychiatric Medications and Risk and Prognosis of Amyotrophic Lateral Sclerosis.
Journal: JAMA network open
Published: June 04, 2025
Plasma troponin T reflects lower motor neuron involvement on electromyography in amyotrophic lateral sclerosis.
Journal: Brain communications
Published: December 10, 2024
Beta-trace protein in chronic inflammatory demyelinating polyradiculoneuropathy and Guillain-Barré syndrome - clinical utilization and a new insight into pathophysiological mechanisms.
Journal: Journal of the neurological sciences
Published: October 29, 2024
Association between cardiometabolic diseases and the risk and progression of motor neuron diseases in Sweden: a population-based case-control study.
Journal: The Lancet regional health. Europe
Published: August 19, 2024
Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy.
Journal: Journal of neuroimmunology
Published: December 28, 2023
Neurodegenerative biomarkers outperform neuroinflammatory biomarkers in amyotrophic lateral sclerosis.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: October 04, 2023
Last Updated: 09/26/2026